课题基金 / 基金详情

CORE-- Protocol-Specific Research Support

CORE-- Protocol-Specific Research Support
CORE——特定协议的研究支持
批准号:
6989963
负责人:
ALEX A. ADJEI
金额:
$9.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-15 至 2009-02-28

项目摘要

项目成果

ALEX A. ADJEI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):目的:支持高质量创新的开展
英文摘要
DESCRIPTION (provided by applicant): Purpose: To support the conduct of high quality innovative feasibility and phase I clinical research protocols. Services: Evaluate and prioritize innovative clinical research concepts; recruit study participants; collect, edit and enter patient data into the computer. Justification: Assessing the feasibility of prevention, diagnosis, and treatment trials often requires the analysis of preliminary data to determine the logistic feasibility and safety of the protocol and treatment. Information gained from the trials promotes the development of phase II trials and generates preliminary data for subsequent grant proposals. Table 1 demonstrates the protocols supported entirely or in part by the PSRS during the previous grant period. 60 protocols were supported from 1999-2002. At the end of 2002, 26 trials were in development as noted in Table 2. As noted by bold type in Table 1, 10 studies have resulted in follow up phase I or II trials either active or in development. The three studies identified by asterisks in Table 1 have resulted in extramural funding or grant proposals. For example, 98-01-12 led to a phase II trial in the North Central Cancer Treatment Group to assess the efficacy of this combination in non-Hodgkin's lymphoma. Dr. Steven Ansell has secured R01 funding to support laboratory components of the trial. Protocol 99-01-02 provided preliminary data leading to a trial in development for ovarian carcinoma and support of Dr. Charles Erlichman's project in a submitted ovarian SPORE application. Organization: Each concept to be considered for Protocol Specific Research Support is reviewed by the disease or discipline oriented group for scientific merit and consistency with the scientific aims of the particular group. A statistician must review the proposed concept and collaborates on study design. Subsequently, the concept is reviewed by the Cancer Center Support Concept Review Committee (Table 3) that meets every other week.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
  • 批准号:
    9815079
  • 项目类别:
  • 资助金额:
    $10.8万
  • 财政年份:
    2018
  • 负责人:
    ALEX A. ADJEI
  • 依托单位:
Phase 2 Clinical Trials Program for Experimental Therapeutics Clinical Trials Network
  • 批准号:
    9094959
  • 项目类别:
  • 资助金额:
    $91.25万
  • 财政年份:
    2014
  • 负责人:
    ALEX A. ADJEI
  • 依托单位:
Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.
NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis
  • 批准号:
    9086290
  • 项目类别:
  • 资助金额:
    $71.82万
  • 财政年份:
    2014
  • 负责人:
    ALEX A. ADJEI
  • 依托单位:
海外基金